NCT06515925 Our Whole Lives Gemini: Virtual Integrative Medical Group Visits for Managing Chronic Pain
| NCT ID | NCT06515925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cambridge Health Alliance |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 212 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 212 participants in total. It began in 2024-08-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research study is to test the efficacy of a non-prescription medicine, web-based platform solution for patients with chronic pain, to improve pain self-management and related outcomes. The main question investigators aim to answer is; would the use of this web-based intervention plus an online group visit compared to control result in better pain-related outcomes and improved pain impact?
Eligibility Criteria
Inclusion Criteria: * English-speaking adults * Over the age of 18 * Experiencing chronic musculoskeletal pain. (Pain may have more than one source; Pain must be non-malignant; Participant must have an average pain intensity of ≥ 4 (1 out of 10) in the past 7 days; Participant must meet the chronic criteria of a pain problem that has persisted at least 3 months, and has resulted in pain on at least half the days in the past 6 months) Exclusion Criteria: * Inability to understand English at a level necessary for informed consent and understanding participation instructions, and participating in the group; * Serious underlying systemic or co-morbid conditions or life event that precludes physical or cognitive ability to participate in the study. * Severe depression * Current mania or psychosis; * Active heroin or cocaine use in the past 3 months * Heavy alcohol use * Known or planned pregnancy
Contact & Investigator
Zev Schuman-Olivier, MD
STUDY DIRECTOR
Cambridge Health Alliance
Frequently Asked Questions
Who can join the NCT06515925 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06515925 currently recruiting?
Yes, NCT06515925 is actively recruiting participants. Contact the research team at pgardiner@challiance.org for enrollment information.
Where is the NCT06515925 trial being conducted?
This trial is being conducted at Malden, United States.
Who is sponsoring the NCT06515925 clinical trial?
NCT06515925 is sponsored by Cambridge Health Alliance. The principal investigator is Zev Schuman-Olivier, MD at Cambridge Health Alliance. The trial plans to enroll 212 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.